A Review of Intervention Strategies for Areca Nut Use Cessation
- PMID: 36925490
- PMCID: PMC10011838
- DOI: 10.1177/02537176221144711
A Review of Intervention Strategies for Areca Nut Use Cessation
Abstract
Background: Areca nut (AN) is one of the world's most widely used drugs, especially in Asia-Pacific, causing dependence and multiple adverse health impacts. The International Agency for Research on Cancer (IARC) has classified it as a type-1 carcinogen. Despite evidence of harms, its use is culturally ingrained in many regions worldwide; harm perception is low; and the availability of intervention strategies is limited.
Methods: To identify the range and efficacy of interventional studies on AN use cessation, a narrative review of studies published between 1990 and 2021 was undertaken using selected electronic databases (PubMed, Embase, and Scopus).
Results: Three types of interventions were identified: educational, psychological, and pharmacological. Overall, educational interventions significantly enhanced knowledge regarding harms related to AN use. Some psychological interventions reported enhancement of motivation to quit as well as helped in reduction/cessation of AN use. Two pharmacological studies on psychiatric patients with depressive disorders and AN use found that antidepressants helped in reducing/cessation of AN use.
Conclusion: Overall, the number of interventional studies on AN cessation is limited, and most studies have measured the short-term effects of the intervention. The role of pharmacotherapeutic interventions needs to be evaluated for AN cessation, and evidence-based psychosocial interventions need to be developed for AN cessation. Furthermore, longitudinal research using adequate sample sizes and longer follow-up durations are needed to establish interventions in this important area.
Keywords: Areca nut; Betel nut; Betel quid; Cessation; Intervention.
© 2023 The Author(s).
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- Gupta PC and Warnakulasuriya S. Global epidemiology of areca nut usage. Addict Biol, 2002; 7(1): 77–83. - PubMed
-
- Lee CH, Ko AM, Warnakulasuriya S, et al.. Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. Int J Cancer, 2011; 129(7): 1741–1751. - PubMed
-
- Arora S and Squier C. Areca nut trade, globalisation and its health impact: perspectives from India and South-east Asia. Perspect Public Health, 2019; 139(1): 44–48. - PubMed
-
- Williams S, Malik A, Chowdhury S, et al.. Sociocultural aspects of areca nut use. Addict Biol, 2002; 7(1): 147–154. - PubMed
-
- WHO International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, vol 85. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. Lyon, France: International Agency for Cancer Research, June 2004. http://monographs.iarc.fr/ENG/Monographs/vol85/mono85.pdf (accessed February 2, 2022). - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
